| Autor: |
Claudio Brancolini, Fulvia Felluga, Fabio Benedetti, Eros Di Giorgio, Giovanni Grignani, Giorgia Giordano, Emiliano Dalla, Raffaella Picco, Francesca D'Este, Martina Minisini, Claudia Maria Cafiero, Ymera Pignochino, Sara Drioli, Luca Iuliano |
| Rok vydání: |
2023 |
| DOI: |
10.1158/1535-7163.c.6543375 |
| Popis: |
Leiomyosarcomas are rare and aggressive tumors characterized by a complex karyotype. Surgical resection with or without radiotherapy and chemotherapy is the standard curative treatment. Unfortunately, a high percentage of leiomyosarcomas recurs and metastasizes. In these cases, doxorubicin and ifosfamide represent the standard treatment but with low response rates. Here, we evaluated the induction of proteotoxic stress as a possible strategy to kill leiomyosarcoma cells in a therapeutic perspective. We show that aggressive leiomyosarcomas coexist with high levels of proteotoxic stress. As a consequence, we hypothesized that leiomyosarcoma cells are vulnerable to further increases of proteotoxic stress. The small compound 2c is a strong inducer of proteotoxic stress. In leiomyosarcoma cells, it triggers cell death coupled to a profound reorganization of the mitochondrial network. By using stimulated emission depletion microscopy, we have unveiled the existence of DIABLO/SMAC clusters that are modulated by 2c. Finally, we have engineered a new version of 2c linked to polyethylene glycol though a short peptide, named 2cPP. This new prodrug is specifically activated by proteases present in the tumor microenvironment. 2cPP shows a strong antitumor activity in vivo against leiomyosarcomas and no toxicity against normal cells. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
